Anatomy of success: The top 100 cited scientific reports focused on hypertension research

Hypertension

Volumn 63, Issue 4, 2014, Pages 641-647

  Oh, Young S ^a   Galis, Zorina S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

AUSTRALIA; BASIC RESEARCH; BELGIUM; BIBLIOMETRICS; BLOOD PRESSURE REGULATION; CORRELATION COEFFICIENT; DENMARK; DRUG EFFICACY; FINLAND; FRANCE; FUNDING; GERMANY; HUMAN; HYPERTENSION; INTERNAL MEDICINE; IRELAND; ITALY; META ANALYSIS (TOPIC); NEPHROLOGY; NETHERLANDS; NONHUMAN; NORWAY; OBSERVATIONAL STUDY; PHARMACOLOGY; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCIENTIFIC LITERATURE; SPAIN; SWEDEN; SWITZERLAND; UNITED KINGDOM; UNITED STATES; UROLOGY; WRITING;

ANIMALS; BIBLIOMETRICS; BIOMEDICAL RESEARCH; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; INTERNATIONALITY; JOURNAL IMPACT FACTOR; LANGUAGE; PUBLICATIONS;

EID: 84897098324     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02677     Document Type: Review

References (37)

1. American Heart Association: Statistical Fact Sheet, 2013 Update, High Blood Pressure. https://www.heart.org/idc/groups/heart-public/@ wcm/@sop/@smd/documents/downloadable/ucm-319587.pdf. Accessed December 2, 2013.
2. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123:933-944.
3. National Institutes of Health. RePORT: estimates of funding for various research, condition, and disease categories (RCDC). http://report.nih.gov/ categorical-spending.aspx. Accessed December 2, 2013.
4. Galis ZS, Thrasher T, Reid DM, Stanley DV, Oh YS. Investing in high blood pressure research: a national institutes of health perspective. Hypertension. 2013;61:757-761.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, Committee NHBPEP. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure-The JNC 7 Report. JAMA. 2003;289:2560-2572.
6. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347-379.
7. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898.
8. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-2428.
9. Rosas SR, Schouten JT, Cope MT, Kagan JM. Modeling the dissemination and uptake of clinical trials results. Res Evaluat. 2013;22:179-186.
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
11. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1939;197:332-343.
12. Goldenberg M, Pines KL. The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension. Am J Med. 1948;5:792-806.
13. Brandt JS, Downing AC, Howard DL, Kofnas JD, Chasen ST. Citation classics in obstetrics and gynecology: the 100 most frequently cited journal articles in the last 50 years. Am J Obstet Gynecol. 2010;203:355. e1-355.e7.
14. Eshraghi M, Habibi G, Rahim MB, Mirkazemi R, Ghaemi M, Omidimorad A, Alavi AA, Banazadeh M. Bibliometric analysis of lung transplantation research articles. Thorac Cardiovasc Surg. 2011;59:108-114.
15. Hennessey K, Afshar K, Macneily AE. The top 100 cited articles in urology. Can Urol Assoc J. 2009;3:293-302.
16. Loomes DE, van Zanten SV. Bibliometrics of the top 100 clinical articles in digestive disease. Gastroenterology. 2013;144:673-676.e5.
17. Ibrahim GM, Snead OC 3rd, Rutka JT, Lozano AM. The most cited works in epilepsy: trends in the "Citation Classics". Epilepsia. 2012;53:765-770.
18. Alberts B. Impact factor distortions. Science. 2013;340:787.
19. Bertuzzi S, Drubin DG. No shortcuts for research assessment. Mol Biol Cell. 2013;24:1505-1506.
20. Misteli T. Eliminating the impact of the Impact Factor. J Cell Biol. 2013;201:651-652.
21. Pulverer B. Impact fact-or fction? EMBO J. 2013;32:1651-1652.
22. Hirsch JE. An index to quantify an individual's scientifc research output. Proc Natl Acad Sci USA. 2005;102:16569-16572.
23. Alonso S, Cabrerizo FJ, Herrera-Viedma E, Herrera F. h-Index: a review focused in its variants, computation and standardization for different sci-entifc felds. J Informetr. 2009;3:273-289.
24. Bornmann L, Daniel HD. The state of h index research. Is the h index the ideal way to measure research performance? EMBO Rep. 2009;10:2-6.
25. Web of Science Help: h-index. http://images.webofknowledge.com/ WOKRS512B4/help/WOS/hp-citation-report-hindex.html. Accessed December 2, 2013.
26. Black HR, Cohen JD, Kaplan NM, et al. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
27. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827-838.
28. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet. 1999;22:239-247.
29. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990-994.
30. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75.
31. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult-population-results from the 3rd national-health and nutrition examination survey, 1988-1991. Hypertension. 1995;25:305-313.
32. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
33. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood-pressure-an independent predictor of prognosis in essential-hypertension. Hypertension. 1994;24:793-801.
34. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541-544.
35. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
36. Marx W, Schier H, Wanitschek M. Citation analysis using online databases: feasibilities and shortcomings. Scientometrics. 2001;52:59-82.
37. Adler R, Ewing J, Taylor P, Hall PG. A Report from the International Mathematical Union (IMU) in Cooperation with the International Council of Industrial and Applied Mathematics (ICIAM) and the Institute of Mathematical Statistics (IMS). Stat Sci. 2009;24:1-28.